Jonny Kinzi

7PUBLICATIONS
7CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPharmacogenomicsWastewater treatment processesMolecular targetsBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 14, 2026
Impact of Efavirenz on Heme Protein Induction and Biomarkers: Insights From In Vitro Experiments and a Clinical Study.

Leila Potzel, Jonny Kinzi, Isabell Seibert

|Jun 20, 2025
Insights Into Atorvastatin Pharmacokinetics in Rats Reveal Regulation of CYP3A1 by Humanization of SLCO2B1.

Jonny Kinzi, Janine Hussner, Isabell Seibert

|Oct 09, 2024
Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe.

Jonny Kinzi, Markus Grube, Isabell Seibert

|Jul 22, 2024
Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in <i>rSlco2b1</i>-Knockout and <i>SLCO2B1</i>-Knockin Rats.

Jonny Kinzi, Janine Hussner, Isabell Seibert

|Mar 06, 2024
Humanization of <i>SLCO2B1</i> in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420.

Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis

|Sep 14, 2023
Various effects of repeated rifampin dosing on coproporphyrin levels in humans.

Jonny Kinzi, Markus Grube, Karin Brecht

Pageof 2